Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Considering the Experimental use of Temozolomide in Glioblastoma Research.
Herbener VJ, Burster T, Goreth A, Pruss M, von Bandemer H, Baisch T, Fitzel R, Siegelin MD, Karpel-Massler G, Debatin KM, Westhoff MA, Strobel H. Herbener VJ, et al. Among authors: debatin km. Biomedicines. 2020 Jun 4;8(6):151. doi: 10.3390/biomedicines8060151. Biomedicines. 2020. PMID: 32512726 Free PMC article. Review.
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy.
Strobel H, Baisch T, Fitzel R, Schilberg K, Siegelin MD, Karpel-Massler G, Debatin KM, Westhoff MA. Strobel H, et al. Among authors: debatin km. Biomedicines. 2019 Sep 9;7(3):69. doi: 10.3390/biomedicines7030069. Biomedicines. 2019. PMID: 31505812 Free PMC article. Review.
RIST: a potent new combination therapy for glioblastoma.
Nonnenmacher L, Westhoff MA, Fulda S, Karpel-Massler G, Halatsch ME, Engelke J, Simmet T, Corbacioglu S, Debatin KM. Nonnenmacher L, et al. Among authors: debatin km. Int J Cancer. 2015 Feb 15;136(4):E173-87. doi: 10.1002/ijc.29138. Epub 2014 Sep 1. Int J Cancer. 2015. PMID: 25123598 Free article.
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy.
Westhoff MA, Karpel-Massler G, Brühl O, Enzenmüller S, La Ferla-Brühl K, Siegelin MD, Nonnenmacher L, Debatin KM. Westhoff MA, et al. Among authors: debatin km. Mol Cell Ther. 2014 Oct 27;2:32. doi: 10.1186/2052-8426-2-32. eCollection 2014. Mol Cell Ther. 2014. PMID: 26056598 Free PMC article. Review.
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
Ströbele S, Schneider M, Schneele L, Siegelin MD, Nonnenmacher L, Zhou S, Karpel-Massler G, Westhoff MA, Halatsch ME, Debatin KM. Ströbele S, et al. Among authors: debatin km. PLoS One. 2015 Jun 29;10(6):e0131670. doi: 10.1371/journal.pone.0131670. eCollection 2015. PLoS One. 2015. PMID: 26121251 Free PMC article.
A paired comparison between glioblastoma "stem cells" and differentiated cells.
Schneider M, Ströbele S, Nonnenmacher L, Siegelin MD, Tepper M, Stroh S, Hasslacher S, Enzenmüller S, Strauss G, Baumann B, Karpel-Massler G, Westhoff MA, Debatin KM, Halatsch ME. Schneider M, et al. Among authors: debatin km. Int J Cancer. 2016 Apr 1;138(7):1709-18. doi: 10.1002/ijc.29908. Epub 2015 Nov 17. Int J Cancer. 2016. PMID: 26519239 Free article.
The effects of PI3K-mediated signalling on glioblastoma cell behaviour.
Langhans J, Schneele L, Trenkler N, von Bandemer H, Nonnenmacher L, Karpel-Massler G, Siegelin MD, Zhou S, Halatsch ME, Debatin KM, Westhoff MA. Langhans J, et al. Among authors: debatin km. Oncogenesis. 2017 Nov 29;6(11):398. doi: 10.1038/s41389-017-0004-8. Oncogenesis. 2017. PMID: 29184057 Free PMC article.
Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells.
Hasslacher S, Schneele L, Stroh S, Langhans J, Zeiler K, Kattner P, Karpel-Massler G, Siegelin MD, Schneider M, Zhou S, Grunert M, Halatsch ME, Nonnenmacher L, Debatin KM, Westhoff MA. Hasslacher S, et al. Among authors: debatin km. Int J Oncol. 2018 Nov;53(5):1881-1896. doi: 10.3892/ijo.2018.4528. Epub 2018 Aug 16. Int J Oncol. 2018. PMID: 30132519 Free PMC article.
Dual metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma.
Pruss M, Dwucet A, Tanriover M, Hlavac M, Kast RE, Debatin KM, Wirtz CR, Halatsch ME, Siegelin MD, Westhoff MA, Karpel-Massler G. Pruss M, et al. Among authors: debatin km. Br J Cancer. 2020 Apr;122(8):1146-1157. doi: 10.1038/s41416-020-0759-0. Epub 2020 Mar 2. Br J Cancer. 2020. PMID: 32115576 Free PMC article.
529 results